|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
and IFN
inversely modulate expression of the IL-17E receptor in Airway Smooth Muscle Cells
1 Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada
2 Departement of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada
3 Departement of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada
* To whom correspondence should be addressed. E-mail: qutayba.hamid{at}mcgill.ca.
The interleukin-17B receptor (IL-17BR) is expressed in a variety of tissues and is upregulated under inflammatory conditions. This receptor binds both its cognate ligand IL-17B and IL-17E/IL-25, a novel cytokine known to promote Th2 responses. The present study illustrates that airway smooth muscle cells express IL-17BR in vitro and that its expression is upregulated by TNF
and downregulated by IFN
. Our data indicates that TNF
upregulates IL-17BR mainly through NF-
B as assessed with the IKK2 inhibitor, AS602868. In addition, both IFN
and dexamethasone are able to antagonize a TNF
-induced IL-17BR increase in mRNA expression. The MEK inhibitor, U0126, totally reversed the inhibition observed with IFN
, suggesting the involvement of the ERK pathway in this effect. In addition, upon stimulation with IL-17E, ASMC increase their expression of extracellular matrix components, namely pro-collagen
1 and lumican mRNA. Furthermore, immunohistochemical analysis of biopsies from asthmatic subjects reveals that this receptor is abundant in smooth muscle layers. This is the first report showing IL-17BR receptor in structural cells of the airways. Our results suggest a potential pro-remodelling effect of IL-17E on airway smooth muscle cells through the induction of extracellular matrix and that its receptor is upregulated by proinflammatory conditions.
This article has been cited by other articles:
![]() |
O. Tliba and Y. Amrani Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Keslacy, O. Tliba, H. Baidouri, and Y. Amrani Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity Mol. Pharmacol., February 1, 2007; 71(2): 609 - 618. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |